UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Standardized remission criteria in schizophrenia

Acta psychiatrica Scandinavica, 2006-02, Vol.113 (2), p.91-95

2006

Link zum Volltext

Verfügbarkeit prüfen

A functional comparison of patients with schizophrenia between the North and South of Europe

European psychiatry, 2012-08, Vol.27 (6), p.442-444

2012

Link zum Volltext

Verfügbarkeit prüfen

Correlates of risk factors for reduced life expectancy in schizophrenia: Is it possible to develop a predictor profile?

Schizophrenia research, 2018-11, Vol.201 (November), p.388-392

2018

Link zum Volltext

Verfügbarkeit prüfen

P03-148 Costs for schizopsychotic patients in Sweden

European psychiatry, 2009, Vol.24, p.S1147-S1147

2009

Link zum Volltext

Verfügbarkeit prüfen

P.3.e.012 How is family burden correlated to the patients’ symptoms, function, quality of life and attitude to medication?

European neuropsychopharmacology, 2008, Vol.18, p.S468-S468

2008

Link zum Volltext

Verfügbarkeit prüfen

Performance-Based Measurement of Functional Disability in Schizophrenia: A Cross-National Study in the United States and Sweden

The American journal of psychiatry, 2009-07, Vol.166 (7), p.821-827

2009

Link zum Volltext

Verfügbarkeit prüfen

Average lifespan among schizophrenia patients is more closely linked to cognitive ability than to symptom activity

Schizophrenia bulletin, 2015, Vol.41, p.S140

2015

Link zum Volltext

Verfügbarkeit prüfen

Marginal relationship between affective dispositions and neurocognitive function in patients with schizophrenia spectrum disorders

Nordic journal of psychiatry, 2021-07, Vol.75 (5), p.344-350

2021

Link zum Volltext

Verfügbarkeit prüfen

P.3.f.003 Illness activity or medical history – what is most important for family burden in schizophrenia? The impact of remission

European neuropsychopharmacology, 2007, Vol.17, p.S498-S498

2007

Link zum Volltext

Verfügbarkeit prüfen

P03-128 - A flexible-dose study of paliperidone ER in non-acute patients with schizophrenia previously unsuccessfully treated with oral risperidone

European psychiatry, 2010, Vol.25 (S1), p.1108-1108, Article 25-E1097

2010

Link zum Volltext

Verfügbarkeit prüfen

Measuring adult Attention Deficit Hyperactivity Disorder using the Quantified Behavior Test Plus

PsyCh journal (Victoria, Australia), 2013-04, Vol.2 (1), p.48-62

2013

Link zum Volltext

Verfügbarkeit prüfen

Objective Measures of Behavior Manifestations in Adult ADHD and Differentiation from Participants with Bipolar II Disorder, Borderline Personality Disorder, Participants with Disconfirmed ADHD as Well as Normative Participants

Clinical practice and epidemiology in mental health, 2012, Vol.8 (1), p.134-143

2012

Link zum Volltext

Verfügbarkeit prüfen

Remission in schizophrenia: Applying recent consensus criteria to refine the concept

Schizophrenia research, 2007-11, Vol.96 (1), p.223-231

2007

Link zum Volltext

Verfügbarkeit prüfen

Psychometric properties of a performance-based measurement of functional capacity

Psychiatry research, 2012, Vol.197 (3), p.290

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta™) in patients with schizophrenia

The international journal of neuropsychopharmacology, 2005-03, Vol.8 (1), p.27-36

2005

Link zum Volltext

Verfügbarkeit prüfen

The weighed core symptom scale and prediction of ADHD in adults - objective measures of remission and response to treatment with methylphenidate

Clinical practice and epidemiology in mental health, 2013, Vol.9 (1), p.171-179

2013

Link zum Volltext

Verfügbarkeit prüfen

Are there different attitudes to medication for patients with psychosis, considering their antipsychotic medication and remission status?

The international journal of neuropsychopharmacology, 2008-07, Vol.11, p.164

2008

Link zum Volltext

Verfügbarkeit prüfen

Costs for Schizopsychotic Patients in Sweden

European psychiatry, 2009-01, Vol.24 (S1), Article 24-E1147

2009

Link zum Volltext

Verfügbarkeit prüfen

Verbal learning in schizopsychotic outpatients and healthy volunteers as a function of cognitive performance levels

Archives of clinical neuropsychology, 2007-02, Vol.22 (2), p.161-174

2007

Link zum Volltext

Verfügbarkeit prüfen

The contribution made by the clinical setting to violence among psychiatric patients

Criminal behaviour and mental health, 1994, Vol.4 (4), p.341-352

1994

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapy for aggressive and violent behaviour: A view of practical management from clinicians

Criminal behaviour and mental health, 1994-11, Vol.4 (4), p.328-340

1994

Link zum Volltext

Verfügbarkeit prüfen

Clinical Overview Article: Standardized remission criteria in schizophrenia

Acta psychiatrica Scandinavica, 2006-02, Vol.113 (2), p.91-95

2006

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, D2 receptor occupancy, and clinical effects of a long-acting injectable formulation of risperidone in patients with schizophrenia

BIOLOGICAL PSYCHIATRY, 2001, Vol.49 (8), p.117S

2001

Link zum Volltext

Verfügbarkeit prüfen

Information fusion supporting team situation awareness for future fighting aircraft

2010 13th International Conference on Information Fusion, 2010, p.1-8

2010

Link zum Volltext
IEEE_Xplore

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(22)
Tagungsberichte
(2)

Sprache

Englisch
(24)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Psychiatry
(12)
Psychology
(10)
Psykologi
(9)
Schizophrenia
(8)
Humans
(7)
Life Sciences & Biomedicine
(7)
Science & Technology
(7)
Adult And Adolescent Clinical Studies
(5)
Biological And Medical Sciences
(5)
Female
(5)
Internal Medicine
(5)
Male
(5)
Medical Sciences
(5)
Psychology. Psychoanalysis. Psychiatry
(5)
Psychopathology. Psychiatry
(5)
Psychoses
(5)
Medicin Och Hälsovetenskap
(4)
Schizophrenia - Diagnosis
(4)
Schizophrenic Psychology
(4)
Adult
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Standardized remission criteria in schizophrenia

A functional comparison of patients with schizophrenia between the North and South of Europe

Correlates of risk factors for reduced life expectancy in schizophrenia: Is it possible to develop a predictor profile?

P03-148 Costs for schizopsychotic patients in Sweden

P.3.e.012 How is family burden correlated to the patients’ symptoms, function, quality of life and attitude to medication?

Performance-Based Measurement of Functional Disability in Schizophrenia: A Cross-National Study in the United States and Sweden

Average lifespan among schizophrenia patients is more closely linked to cognitive ability than to symptom activity

Marginal relationship between affective dispositions and neurocognitive function in patients with schizophrenia spectrum disorders

P.3.f.003 Illness activity or medical history – what is most important for family burden in schizophrenia? The impact of remission

P03-128 - A flexible-dose study of paliperidone ER in non-acute patients with schizophrenia previously unsuccessfully treated with oral risperidone

Measuring adult Attention Deficit Hyperactivity Disorder using the Quantified Behavior Test Plus

Objective Measures of Behavior Manifestations in Adult ADHD and Differentiation from Participants with Bipolar II Disorder, Borderline Personality Disorder, Participants with Disconfirmed ADHD as Well as Normative Participants

Remission in schizophrenia: Applying recent consensus criteria to refine the concept

Psychometric properties of a performance-based measurement of functional capacity

Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta™) in patients with schizophrenia

The weighed core symptom scale and prediction of ADHD in adults - objective measures of remission and response to treatment with methylphenidate

Are there different attitudes to medication for patients with psychosis, considering their antipsychotic medication and remission status?

Costs for Schizopsychotic Patients in Sweden

Verbal learning in schizopsychotic outpatients and healthy volunteers as a function of cognitive performance levels

The contribution made by the clinical setting to violence among psychiatric patients

Pharmacotherapy for aggressive and violent behaviour: A view of practical management from clinicians

Clinical Overview Article: Standardized remission criteria in schizophrenia

Pharmacokinetics, D2 receptor occupancy, and clinical effects of a long-acting injectable formulation of risperidone in patients with schizophrenia

Information fusion supporting team situation awareness for future fighting aircraft

Suchergebnisse filtern